Deep Dive: Cell Therapy
BioAlps and BioArk are delighted to present "Deep Dive: Cell Therapy", an exclusive event dedicated to addressing the endless possibilities of cell therapy.
From regenerative medicine to tissue engineering, cell therapy is a groundbreaking approach to treating various medical conditions, with the power to impact patient care and reshape our understanding of medicine and disease.
Get inspiring insights from our selected panel of speakers with companies at the forefront of innovation including Resea Biotec and Cytiva.
Be a part of the conversation and exchange with experts to shape the future of healthcare.
Don't miss this unique opportunity to gain valuable knowledge, network with industry leaders, and discuss the state of the art of cell therapy.
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
